Business
September 27, 2024
6 views 25 secs 0

Zomato Co-Founder Akriti Chopra Resigns After 13 Years

New Delhi: Zomato’s co-founder and Chief People Officer, Akriti Chopra, has stepped down from her position effective immediately, concluding her 13-year journey with the food delivery giant. The company announced this news to the stock exchange on September 27. “Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform that Ms. Akriti […]

Business
September 27, 2024
3 views 5 mins 0

Pakistan receives first tranche of $1.02bn from IMF under EFF

State Bank of Pakistan (SBP) on Friday received the first tranche of SDR 760 million (equivalent to $1.0269 billion) from the International Monetary Fund (IMF) under the $7 billion Extended Fund Facility (EFF). The IMF Executive Board approved a 37-month programme on Wednesday. These inflows will be reflected in SBP liquid reserves to be released […]

Business
September 27, 2024
5 views 35 secs 0

PSX drops as KSE-100 Index falls

The Pakistan Stock Exchange (PSX) witnessed a decline on Friday, with the benchmark KSE-100 Index falling by 198 points. The index is currently trading at 81,459 points. The dip comes after a period of relative stability, prompting market participants to keep a close eye on upcoming economic developments and corporate earnings reports. On Thursday, the […]

Business
September 27, 2024
3 views 6 mins 0

Daily Telegraph tipped to go to US bidder at auction

The owner of the politically right-leaning New York Sun has emerged as the favourite to acquire the Daily and Sunday Telegraph ahead of Friday’s deadline for bids. Though a late entrant to the auction British-born Dovid Efune’s bid is considered by several parties as the potential new frontrunner. He is thought able to offer a […]

Business
September 26, 2024
5 views 9 mins 0

FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades

Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades.  Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia, […]

Business
September 26, 2024
4 views 44 secs 0

Swiggy Files for IPO, Aims to Raise About $450 Million

Last Updated: September 26, 2024, 22:24 IST Existing shareholders including Accel India and Tencent Europe will sell about 185.3 million shares, the Bengaluru-based startup said in its draft prospectus. Swiggy’s long-awaited public listing comes amid a booming IPO market, with 198 companies having raised $7.1 billion in the year to Sept.4, more than double the […]

Business
September 26, 2024
1 views 2 mins 0

Govt To Borrow Rs 6.61 Lakh Crore In Second Half Of Current Fiscal

New Delhi: The government on Thursday said it plans to borrow Rs 6.61 lakh crore in the second half of the current fiscal through the issuance of dated securities, including Rs 20,000 crore of Sovereign Green Bonds (SGrBs). The government, in consultation with the Reserve Bank of India (RBI), has finalised its borrowing programme for […]

Business
September 26, 2024
1 views 3 mins 0

E2E Job Creation 100 List for 2024 unveiled

E2E is excited to reveal the E2E Job Creation 100 list for 2024, in collaboration with The Independent. This exclusive list celebrates those companies that have had the highest absolute growth in jobs over the two most recent filing periods, with a percentage growth in staff above 25%. The E2E Job Creation 100 list pays […]

Business
September 26, 2024
3 views 3 mins 0

Employment rights and the creation of technology, software and brands

The UK economy is now more dependent than ever on the creators within companies who innovate. Over 50% of global patent applications now involve software of some kind. This is an amazing statistic when you think that under UK and EU law, software per se is not patentable. However, the technical effects of a patent […]